Fundz

Drug discovery platform Peptris raises Rs 70 Cr in Series A round co-led by IAN Alpha Fund and Speciale Invest to advance its programs and expand its pipeline.

PRIVATEFeb 18, 2026

Amount Raised

₹700 Million

Round Type

Series A

BengaluruBiotechnology Research

Investors

Byt VenturesTenacity VenturesIAN Alpha FundSpeciale Invest

Description

Peptides has raised Rs 70 crore ($7.7 million) in a Series A funding round. The capital will enhance teams across various fields and advance its existing programs toward clinical readiness. The Bengaluru-based company addresses challenges in drug discovery by generating novel molecules through AI. Peptris aims to initiate multiple new NCE programs and accelerate drug development.

Quick answer

Peptris Technologies raised ₹700 Million in a Series A round, dated February 18, 2026. Investors: Byt Ventures, Tenacity Ventures, IAN Alpha Fund and Speciale Invest. Peptris Technologies is based in Bengaluru, Karnataka, India.

How much did Peptris Technologies raise?
Peptris Technologies raised ₹700 Million in a Series A round on February 18, 2026.
Who invested in Peptris Technologies?
Byt Ventures, Tenacity Ventures, IAN Alpha Fund and Speciale Invest are named as investors in this round.
What does Peptris Technologies do?
Peptris is an AI powered preclinical drug discovery company working on oncology, inflammation and rare diseases.
Where is Peptris Technologies based and how big is it?
Peptris Technologies is based in Bengaluru, Karnataka, India.
Who are the decision-makers at Peptris Technologies?
Fundz holds 1 contact at Peptris Technologies. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research around the same time

Companies in the same sectors as Peptris Technologies that raised within 45 days of this round, from Fundz verified event records.

  • Ora Biomedical raised $205K (Pre-Seed) on January 19, 2026.

Who to call at Peptris Technologies, and when

A new round usually means Peptris Technologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Peptris Technologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Peptris Technologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Peptris Technologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Peptris Technologies

Location

Bengaluru, Karnataka, India

About

Peptris is an AI powered preclinical drug discovery company working on oncology, inflammation and rare diseases. At Peptris, we have created an array of AI models to predict various parameters that are critical for a novel molecule to be considered a potential drug candidate. All these models are orchestrated by an automated pipeline that prunes large purchasable compound datasets to identify potential hits and also creates denovo variations of compounds that are predicted to be novel, potent, safe, selective, and active clinically. The pipeline ensures that the number of compounds to be tested and validated in a wet lab are minimal, making our discovery efficient, faster and cost effective. We have some exciting wet lab results from our proprietary discovery programs and we are currently accelerating them into preclinical development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Peptris Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Peptris Technologies's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Peptris Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.